Metraipolis › archive › dc_c350bc985c04
Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR) — Europe PMC PMID:41258942
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41258942
- DOI
- 10.1007/s00415-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T10:37:40.820Z
- SHA-256 of the archived text
23d1a3c8bc542de0fe5e6a4fb6c35fd77a5c0f23c5d3d0ef431c4fa6caf3a437- Stable URL of this page
https://metraipolis.com/documento/dc_c350bc985c04
How to cite
Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR) — Europe PMC PMID:41258942 — Europe PMC (en), https://europepmc.org/article/MED/41258942 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c350bc985c04 (Metraipolis archive dc_c350bc985c04, sha256 23d1a3c8bc542de0fe5e6a4fb6c35fd77a5c0f23c5d3d0ef431c4fa6caf3a437)
BibTeX
@misc{dcc350bc985c04,
title = {Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR) — Europe PMC PMID:41258942},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41258942},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c350bc985c04; sha256 23d1a3c8bc542de0fe5e6a4fb6c35fd77a5c0f23c5d3d0ef431c4fa6caf3a437},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41258942. Agents can read the archived copy with the MCP tool read_document.